Status: Recruiting
Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary Efficacy of FS-8002
this is a single-arm, open phase I clinical trial evaluating the safety, tolerability, pharmacokinetics, pharmacokinetics, and preliminary efficacy of FS-8002 and combination therapy in patients with advanced solid tumors
Participants needed: 66
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai Pushi Medical Science Co. LtdUpdated: Aug 4, 2026Locations: 10
Eligibility criteria
Patients with advanced solid tumors confirmed by histology or cytology who have... [+2]
Patients who have previously received TGF-β inhibitor therapy. previous treatmen... [+4]